Cited by 941Substance Abuse Treatment and OutcomesMental Health Treatment and AccessBipolar Disorder and Treatment

The DOI matches its Crossref record; 111 of the 113 references it cites were found in a registry or an index.

Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis

Open access

Lai, Harry Man Xiong, Cleary, Michelle, Sitharthan, Thiagarajan, Hunt, Glenn E.·2015·Drug and Alcohol Dependence

DOI 10.1016/j.drugalcdep.2015.05.031

Open this paper in CoChat — free account

Abstract

Background Comorbidity is highly prevalent between substance use disorders (SUDs), mood and anxiety disorders. We conducted a systematic review and meta-analysis to determine the strength of association between SUDs, mood and anxiety disorders in population-based epidemiological surveys.Methods A comprehensive literature search of Medline, EMBASE, CINAHL, PsychINFO, Web of Science, and Scopus was conducted from 1990 to 2014. Sources were chosen on the basis that they contained original research in non-clinical populations conducted in randomly selected adults living within defined boundaries. Prevalence of comorbid SUDs, mood and anxiety disorders and odds ratios (ORs) were extracted.Results There were 115 articles identified by electronic searches that were reviewed in full text which yielded 22 unique epidemiological surveys to extract lifetime and 12-month prevalence data for psychiatric illness in respondents with an SUD. Meta-analysis indicated the strongest associations were between illicit drug use disorder and major depression (pooled OR 3.80, 95% CI 3.02-4.78), followed by illicit drug use and any anxiety disorder (OR 2.91, 95% CI 2.58-3.28), alcohol use disorders and major depression (OR 2.42, 95% CI 2.22-2.64) and alcohol use disorders and any anxiety disorder (OR 2.11, 95% CI 2.03-2.19). ORs for dependence were higher than those for abuse irrespective to diagnoses based on lifetime or 12-month prevalence.Conclusions This review confirms the strong association between SUDs, mood and anxiety disorders. The issue has now been recognised worldwide as a factor that affects the profile, course, patterns, severity and outcomes of these disorders.

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2015.05.031

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results From the National Comorbidity Survey
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988

Show all 113 references

Research works printed but not linked: 3

Alonso, 2007, Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD), J. Clin. Psychiatry, 68, 3
Caraveo-Anduaga, 2002, Psychiatric disorders and substance abuse in Mexico: epidemiological perspective, Salud Mental, 25, 9
Ravelli, 1998, Comorbidity of psychiatric disorders in the Dutch population; results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) (Dutch), Tijdschrift voor Psychaitrie, 40, 531

Sorted by citations

Items 901–940 of 940

High‑Resolution Clinical Profiling of Age and Sex Differences in Substance Use Severity, Comorbidity, and Impulsivity in Two Large Treatment Samples
Halladay, J. E., Gendy, M. N. S., Little, Hira, V., Taisir, R., Rahman, L., Britton, E. M., Shantz, R. N., Levitt, E. E., Amlung, M. T., et al. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2670633
Early Trajectory of Depressive Symptoms in Alcohol Dependence: Insights From a Four-Week Clinical Decision Window
Raja, D., Singh, A., & Singh, H. (2026) · Cureus · doi:10.7759/cureus.110864
Strengthening evidence-based practices in assessment and treatment planning for substance use disorder: an evaluation of a Swedish training program for social services
Lundgren, L. M., Jemberie, W. B., Sandlund, M., Nyström, S., Nilsson, M. B., & Grahn, R. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1834745
Epidemiologie: Prävalenzen, Verlauf und Komorbidität
Janssen, S., & Schnell, T. (2026) · Essentials · doi:10.1007/978-3-662-73854-2_4
Drug use disorders in women
Mauro, P. M., West, B. S., Bruzelius, E., Gutkind, S., Carey, E., & Philbin, M. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00095-0
Mental and somatic multimorbidity among individuals with alcohol use disorder: A sex-stratified registry study.
Scarth, M., Bjørnebekk, A., Bramness, J., Abebe, D. S., & Stavseth, M. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113248
Digitally delivered cognitive bias modification for interpretation targeting hostile interpretation bias in compulsory drug rehabilitation: A feasibility randomized trial
Yalikun, S., Ye, Z., Qiao, J., Du, X., Isak, G., Liu, L., & Ren, Z. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117313
Gabapentin: a newly emerging drug of abuse, neurotoxicity, and potential addictive mechanisms
El-Kattan, M., Saeed, E., Khattab, M. A., Maksoud, F. A., Eldein, M. E., Abdel-Roaf, N. E., Awad, W., & Elshatory, A. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-00976-x
Treating addiction with an addictive drug: the ketamine paradox revisited
Hakami, A. Y. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1866092
Comparing Therapeutic Treatment Goals Across Settings for Those in or At-Risk for Substance Use Treatment in West Alabama
Doudell, K. R., Carranza, E., Cassell, J., Buxton, M. R., Jensen, C. M., Witte, T. H., Jarrett, M. A., Cox, B. J., McKinney, R., Jacobs, M. L., et al. (2026) · Substance Use & Addiction Journal · doi:10.1177/29767342261453766
Substance use and mental health outcomes among gay and bisexual men in South Korea: a cross-sectional study
Jeong, S.-J., Kim, B., Lee, H., & Lee, H. (2026) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2026.100728
Ketamine for substance use disorders: a systematic review and meta-analysis
Fang, S.-P., Yang, X., Zhao, D.-C., Wen, Y., Liu, Y.-H., Li, Z., & Ran, M. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1835709
Assessing the Association Between Discrimination and Alcohol Use by Gender Among Latino/a Immigrant Parents: A Cross-sectional Study
Burgos, M. A. M., Bautista, T. G., Barger, S. D., Schwartz, S. J., & Montero‐Zamora, P. (2026) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-026-01965-1
Unemployment & opioid use disorder – socio-medical assessment results by the Medical Service of the German Federal Employment Agency
Soyka, M., Manz, K. M., & Franke, A. G. (2026) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-026-00752-3
Who leaves satisfied? Exploring individual factors associated with substance use disorder service satisfaction
Casper, M., Cioffi, C. C., & Leve, L. D. (2026) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2026.210074
The European drug index: Measuring and comparing national substance use across the European Union to aid policy and planning
Murphy, E., Comiskey, C. M., Walsh, P. P., & Murphy, E. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105451
Prevalence of anxiety and depression symptoms under population-level alcohol reduction to low-risk drinking: A parametric g-computation analysis in a U.S. nationwide cohortPreprint
Sanborn, J., Nash, D., Robertson, M. M., Parcesepe, A. M., & Shahn, Z. (2026) · medRxiv · doi:10.64898/2026.07.31.26359417
Exploring the Pleiotropic Genetic Architecture of Substance Use Disorders: Findings From Phenome-Wide Association Studies
Hartwell, E. E., & Kember, R. L. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100802
Effects of Lavender Inhalation Aromatherapy on Depression in Individuals Undergoing Drug Treatment for Substance Dependence: A Randomized Clinical Trial
Korrani, Z. S., Musarezaie, A., Naraghirad, M., & Rezazadeh, M. (2026) · Health Science Reports · doi:10.1002/hsr2.72796
Data-driven subtypes of internalizing and functional somatic symptoms: A hybrid mixture modeling approach
Saini, U., Wanders, R., Oldehinkel, A. J., Rosmalen, J. G. M., & van Loo, H. M. (2026) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2026.08.006
Improving Screening for Adolescent Substance Use and Mental Health in Primary Care
Shaikh, U., Correa, A. B., Monti, J., Rahmandar, M. H., & Courtlandt, C. (2026) · American Journal of Medical Quality · doi:10.1097/jmq.0000000000000337
Gender disparities in patterns and outcomes of substance use disorder among psychiatric inpatients in Southeastern Nigeria: A retrospective study
Abimbola, U. K., Ijere, I. N., Nwaoru, C. R., Iloma, D. O., & Okoli, E. S. (2026) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2026.210096
Revisión bibliográfica sobre la comorbilidad de la ansiedad infantil
Sánchez, R. G., & Bravo, S. P. (2025) · MEDICA REVIEW International Medical Humanities Review / Revista Internacional de Humanidades Médicas · doi:10.62701/revmedica.v13.5431 · Cited by 2
Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice
Lovell, T. N., James, P. B., Hodgins, S. L., Noya, S. J., Arner, P., & Bobadilla, A. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261478613
Association of tobacco use with seizures, psychosocial comorbidities, and quality of life among people with epilepsy: A cross-sectional analysis
Czerniak, K. W., Sepulveda, R., Youngran, K., Myneni, S., Addy, R. C., Wali, S., Martin, K., Thomas, S., Labiner, D. M., & Shegog, R. (2026) · Epilepsy Research · doi:10.1016/j.eplepsyres.2026.107905
Lifetime Substance Use Disorder in 4250 Bipolar and Major Depressive Disorder Patients
Miola, A., Tondo, L., & Baldessarini, R. J. (2026) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-026-01718-z
The Implementation of Current UK Guidance for the Treatment of Co-Occurring Mental Health and Substance Use Conditions: A Mixed Methods Systematic Review and Thematic Synthesis
Swithenbank, Z., Irizar, P., Halsall, L., Puddephatt, J., Parkes, P., O'Donnell, A. J., Angus, C., Drummond, C., Jackson, K., & Goodwin, L. (2026) · Journal of Dual Diagnosis · doi:10.1080/15504263.2026.2726794
Sex and Age Differences in Prevalence of Psychiatric Conditions Comorbid With Substance Use Disorders Among Military Veterans
Chilton, R., Sippel, L. M., van Engelen, L., & Hoff, R. A. (2026) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001881
Mental Health Problems Among Unaccompanied Refugee Minors Treated for Substance Abuse
Ivert, A., & Magnusson, M.-M. (2026) · Springer eBooks · doi:10.1007/978-3-032-32399-6_8
Mental health and substance use in Europe: initial steps towards a common European approach
Montanari, L., Fonseca, F., Auriacombe, M., Baldacchino, A. M., Bò, A., Fischer, G., Hasselberg, I., Kastelič, A., Kokkolis, K., Malliori, M., et al. (2026) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2026.10212
Meaning in Life, Substance Use Severity, and Depressive Symptoms in Adolescents with Substance Use Disorder
Şirin, H., Sivri, İ., Akdağ, B., & Uzun, M. E. (2026) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1981618
Co-Occurring Mental Illness and Substance Use Disorders: Associations Between Illness Severity, Perceived Need, and Receiving Substance Use Treatment
Waghmare, S. A., Shearer, R. D., Segel, J. E., & Jones, A. A. (2026) · Substance Use Research and Treatment · doi:10.1177/29768357261492867
Sex differences in the associations between symptom severity, social cognition, and connectivity between default mode sub-networks in alcohol use disorder
Cohen‐Gilbert, J. E., Waters, A., Chernyak, S. V., Janes, A. C., Killgore, W. D. S., Greenfield, S. F., Silveri, M. M., & Nickerson, L. D. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113377
Cross-sectional network structure of alexithymia, empathy, anxiety, and depression in male inpatients with alcohol use disorder
Liu, Y., Liu, H., Mu, D., 隋华杰, Ma, Y., & Xiangjuan, K. (2026) · Acta Psychologica · doi:10.1016/j.actpsy.2026.107918
Anxiety and depression symptoms in Chinese male patients with substance use disorder: Independent and comorbid networks
Li, S., He, Y., He, C., Yang, H. M., Nie, Y., & Tang, Y. (2026) · Journal of Health Psychology · doi:10.1177/13591053261488514
Alcohol Use Trajectories Across Disasters: Associations With Depression and Illness Anxiety
Ayer, L. A., Atshan, S., Seelam, R., Ghosh‐Dastidar, B., Harding, A. B., Parker, A. M., & Parks, V. (2026) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70389
Substance use diagnoses among patients who present to federally run mental health facilities with co-morbid ADHD and bipolar disorder between 2013-2023: a national analysis using random forest methods
Ramdin, C., Lister, J. J., Kurtzman, E. T., Kuo, S. I., Shiau, S., Greller, H., & Nelson, L. S. (2026) · Journal of Addictive Diseases · doi:10.1080/10550887.2026.2733227
Chapter 33. Alcohol and Substance Use Disorders
Levin, J., Zysman, W. D., Devireddy, V. R., & Karlin‐Zysman, C. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551319.lg33
Mental health support during ongoing substance use: are people being asked to get well before they can access help?
Ogilvie, L. (2026) · Mental Health and Social Inclusion · doi:10.1108/mhsi-10-2026-0412
Managing coexisting depression and substance use disorder: insights from clinical experience
Schifano, F., Martinotti, G., Wojnar, M., de Melo, I. H., Korbel, C., & Sani, G. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1919720

Authors: Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E.
Affiliations: The University of Sydney (AU)
Western Sydney University (AU)
Corresponding author: Hunt, Glenn E.
ORCID: Lai, Harry Man Xiong
Cleary, Michelle
Hunt, Glenn E.
Venue: Drug and Alcohol Dependence
Publisher: Elsevier BV
Published: 2015-09
Volume: 154
Pages: 1-13
ISSN: 0376-8716 (ISSN-L)
DOI: 10.1016/j.drugalcdep.2015.05.031
OpenAlex: W1494270537
Cited by: 941
References: 113
Citations by year: 2026: 86 · 2025: 96 · 2024: 101 · 2023: 92 · 2022: 91 · 2021: 102 · 2020: 150 · 2019: 85 · 2018: 60 · 2017: 43 · 2016: 26 · 2015: 7
FWCI: 5.89
Type: journal article
Language: en
Open access: green
figshare.com
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Drug and Alcohol Dependence (publishedVersion)
PubMed (publishedVersion)
eCite Digital Repository (University of Tasmania) (submittedVersion)
Figshare (submittedVersion, cc-by)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords: substance use disorders, psychiatric comorbidity, mood disorders, anxiety disorders, major depressive disorder, illicit drug use, alcoholism, substance dependence, substance abuse, prevalence, lifetime prevalence, 12-month prevalence
MeSH terms: Adult, Anxiety Disorders, Depressive Disorder, Major, Major Depressive Disorder, Humans, Comorbidity, Prevalence, Odds Ratio, Substance-Related Disorders, Alcohol-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks